Advertisement

Sports Applications of Creatine

  • Richard B. Kreider
Chapter

Abstract

Creatine remains one of the most extensively studied nutritional ergogenic aids available for athletes. Hundreds of studies have reported that increasing muscle creatine stores through creatine supplementation can augment muscle creatine content, improve exercise and training adaptations, and/or provide some therapeutic benefit to some clinical populations. Consequently, creatine represents one of the most effective and popular nutritional ergogenic aids available for athletes. The future of creatine research is very promising. Researchers are attempting to determine ways to maximize creatine storage in the muscle, which types of exercise may obtain the greatest benefit from creatine supplementation, the potential medical uses of creatine, and the long-term safety and efficacy of creatine supplementation. Among these, the most promising area of research is determining the potential medical uses of creatine, particularly in patients with creatine synthesis deficiencies and neuromuscular diseases. Nevertheless, in regard to athletes, creatine has continually proved itself to be one of the most effective and safe nutritional supplements to increase strength, muscle mass, and performance. This is despite oftentimes inaccurate and misleading information that has been written about creatine in the popular media over the last several years.

Key Words

creatine phosphagen creatine phosphate amino acid hydration ergogenic aid 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chanutin A. The fate of creatine when administered to man. J Biol Chem 1926;67: 29-34.Google Scholar
  2. 2.
    Hultman E, Bergstrom r, Spreit L, Soderlund K. Energy metabolism and fatigue. In:Taylor A, Gollnick PD, Green H, eds. Biochemistry of Exercise VII. Champaign, IL: Human Kinetics Publishers; 1990:73-92.Google Scholar
  3. 3.
    Balsom PD, Soderlund K, Ekblom B. Creatine in humans with special reference to creatine supplementation. Sports Med 1994;18:268-280.CrossRefGoogle Scholar
  4. 4.
    Greenhaff P. The nutritional biochemistry of creatine. r Nutr Biochem 1997;11:610-618.Google Scholar
  5. 5.
    Greenhaff PL. Muscle creatine loading in humans: procedures and functional and metabolic effects. Sixth International Conference on Guanidino Compounds in Biology and Medicine. Cincinnati, OH, 2001.Google Scholar
  6. 6.
    Greenhaff P, Casey A, Green AL. Creatine supplementation revisited: an update. Insider 1996;4:1-2.Google Scholar
  7. 7.
    Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Colch) 1992;83:367- 374.Google Scholar
  8. 8.
    Hultman E, Soderlund K, Timmons JA, Cederblad G, Greenhaff PL. Muscle creatine loading in men. J Appl Physiol 1996;81:232- 237.Google Scholar
  9. 9.
    Burke DC, Smith-Palmer T, Holt LE, Head B, Chilibeck PD. The effect of 7 days of creatine supplementation on 24-hour urinary creatine excretion. J Strength Cond Res 2001;15:59-62.Google Scholar
  10. 10.
    Williams MH, Branch JD. Creatine supplementation and exercise performance: an update. J Am Coll Nutr 1998;17:216-234.Google Scholar
  11. 11.
    Williams MH, Kreider R, Branch JD. Creatine: the power supplement. Champaign, IL: Human Kinetics Publishers; 1999.Google Scholar
  12. 12.
    Burke DG, Chilibeck PD, Parise G, Candow DG, Mahoney D, Tarnopolsky M. Effect of creatine and weight training on muscle creatine and performance in vegetarians. Med Sci Sports Exerc 2003;35:1946-1955.CrossRefGoogle Scholar
  13. 13.
    DeCrauw T1, Cecil KC, Salomons GS, et al. The clinical syndrome of creatine transporter deficiency. Abstracts of 6th International Conference on Guanidino Compounds in Biology and Medicine, 2001.Google Scholar
  14. 14.
    Stockier S, Hanefeld F. Guanidinoacetate methyltransferase deficiency: a newly recognized inborn error of creatine biosynthesis. Wien Klin Wochenschr 1997;109:86-88.Google Scholar
  15. 15.
    Kreider RB. Effects of creatine supplementation on performance and training adaptations. Mol Cell Biochem 2003;244:89-94.CrossRefGoogle Scholar
  16. 16.
    Wallimann T, Dolder M, Neumann D, Schlattner U. Compartmentation, structure, and function of creatine kinases: a rationale for creatine action. Abstracts of 6th International Conference on Guanidino Compounds in Biology and Medicine, 2001.Google Scholar
  17. 17.
    Bessman S, Savabi F. The role of phosphocreatine energy shuttle in exercise and muscle hypertrophy. In: Conway MA, Clark JF, eds. Creatine and Creatine Phosphate: Scientific and Clinical Perspectives. San Diego: Academic Press; 1988:185-198.Google Scholar
  18. 18.
    Wallimann T, Dolder M, Schlattner U, et al. Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology. Biofactors 1998;8:229-234.CrossRefGoogle Scholar
  19. 19.
    Clark JF, Field ML, Ventura-Clapier R. An introduction to the cellular creatine kinase system in contractile tissue. In: Conway MA, Clark JF, eds. Creatine and Creatine Phosphate: Scientific and Clinical Perspectives. San Diego: Academic Press; 1996:51-64.Google Scholar
  20. 20.
    Clark JF. Creatine and phosphocreatine: a review of their use in exercise and sport. J Athl Train 1997;32:45- 50.Google Scholar
  21. 21.
    Ma TM, Friedman DL, Roberts R. Creatine phosphate shuttle pathway in tissues with dynamic energy demand. In: Conway MA, Clark JF, eds. Creatine and Creatine Phosphate: Scientific and Clinical Perspectives. San Diego: Academic Press; 1996:17-32.Google Scholar
  22. 22.
    van Deursen J, Heerschap A, Oerlemans F, et al. Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell 1993;74:621-631.CrossRefGoogle Scholar
  23. 23.
    Askenasy N, Koretsky AP. Differential effects of creatine kinase isoenzymes and substrates on regeneration in livers of transgenic mice. Am J Physiol 1997;273:C741-746.Google Scholar
  24. 24.
    Willoughby DS, Rosene JM. Effects of oral creatine and resistance training on myogenic regulatory factor expression. Med Sci Sports Exerc 2003;35:923-929.CrossRefGoogle Scholar
  25. 25.
    Wyss M, Schulze A. Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience 2002;112:243-260.CrossRefGoogle Scholar
  26. 26.
    Tarnopolsky MA, Parshad A, Walzel B, Schlattner U, Wallimann T. Creatine transporter and mitochondrial creatine kinase protein content in myopathies. Muscle Nerve 2001;24:682-688.CrossRefGoogle Scholar
  27. 27.
    Hespel P, Eijnde BO, Derave W, Richter EA. Creatine supplementation: exploring the role of the creatine kinase/phosphocreatine system in human muscle. Can J Appl Physiol 2001;26:S79- 102.Google Scholar
  28. 28.
    Felber S, Skladal D, Wyss M, Kremser C, Koller A, Sperl W. Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study. Neural Res 2000;22:145-150.Google Scholar
  29. 29.
    Matthews RT, Yang L, Jenkins BG, et al. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J Neurosci 1998;18:156-163.Google Scholar
  30. 30.
    Newsholme E, Beis I. Old and new ideas on the roles of phosphagens and the kinases. In: Conway MA, Clark JF, eds. Creatine and Creatine Phosphate: Scientific and Clinical Perspectives. San Diego: Academic Press; 1996:3-15.Google Scholar
  31. 31.
    Blei ML, Conley KE, Kushmerick MJ. Separate measures of ATP utilization and recovery in human skeletal muscle. J Physiol 1993;465:203-222.Google Scholar
  32. 32.
    Radda GK. Control of energy metabolism during energy metabolism. Diabetes 1996;45:S88-S92.Google Scholar
  33. 33.
    Kreider RB, Leutholtz BC, Greenwood M. Crcatine. In: Wolinsky I, Driskell J, eds. Nutritional Ergogenic Aids. Boca Raton, FL: CRC Press LLC; 2004:81-104.Google Scholar
  34. 34.
    Steenge GR, Simpson EJ, Greenhaff PL. Protein- and carbohydrate-induced augmentation of whole body creatine retention in humans. J Appl Physiol 2000;89:1165-1171.Google Scholar
  35. 35.
    Green AL, Hultman E, Macdonald lA, Sewell DA, Greenhaff PL. Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans. Am J Physiol 1996;271:E821-826.Google Scholar
  36. 36.
    Willoughby DS, Rosene J. Effects of oral creatine and resistance training on myosin heavy chain expression. Med Sci Sports Exerc 2001;33:1674-1681.CrossRefGoogle Scholar
  37. 37.
    Greenhaff PL, Casey A, Short AH, Harris R, Soderlund K, Hultman E. Influence of oral creatine supplementation of muscle torque during repeated bouts of maximal voluntary exercise in man. Clin Sci (Coleh) 1993;84:565-571.Google Scholar
  38. 38.
    Greenhaff PL, Bodin K, Soderlund K, Hultman E. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol 1994;266:E725-730.Google Scholar
  39. 39.
    Vandenberghe K, Goris M, Van Hecke P, Van Leemputte M, Vangerven L, Hespel P. Long-term creatine intake is beneficial to muscle performance during resistance training. J Appl Physiol 1997;83:2055-2063.Google Scholar
  40. 40.
    Kreider R, Greenwood M, Melton C, et al. Long-term creatine supplementation during training/competition does not increase perceptions of fatigue or adversely affect health status. Med Sci Sport Exerc 2002;34:S146.Google Scholar
  41. 41.
    Nelson AG, Arnall DA, Kokkonen J, Day R, Evans J. Muscle glycogen supercompensation is enhanced by prior creatine supplementation. Med Sci Sports Exerc 2001;33:1096-1100.Google Scholar
  42. 42.
    van Loon LJ, Murphy R, Oosterlaar AM, et al. Creatine supplementation increases glycogen storage but not GLUT-4 expression in human skeletal muscle. Clin Sci (Lond) 2004;106:99-106.CrossRefGoogle Scholar
  43. 43.
    Op ‘t Eijnde B, Richter EA, Henquin TC, Kiens B, Hespel P. Effect of creatine supplementation on creatine and glycogen content in rat skeletal muscle. Acta Physiol Scand 2001;171:169-176.CrossRefGoogle Scholar
  44. 44.
    Kehnder M, Rico-Sanz J, Kuhne G, Dambach M, Buchli R, Boutellier U. Muscle phosphocreatine and glycogen concentrations in humans after creatine and glucose polymer supplementation measured noninvasively by 31P and 13 C-MRS. Med Sci Sports Exerc 1998;30:S264.Google Scholar
  45. 45.
    Volek JS, Duncan ND, Mazzetti SA, et al. Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. Med Sci Sports Exerc 1999;31:1147-1156.CrossRefGoogle Scholar
  46. 46.
    Stone MH, Sanborn K, Smith LL, et al. Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players. Int J Sport Nutr 1999;9:146-165.Google Scholar
  47. 47.
    Kreider RB, Ferreira M, Wilson M, et al. Effects of creatine supplementation on body composition, strength, and sprint performance. Med Sci Sports Exerc 1998;30:73-82.Google Scholar
  48. 48.
    Earnest CP, Snell P, Rodriguez R, Almada A, Mitchell TL. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand 1995;153:207-209.CrossRefGoogle Scholar
  49. 49.
    Volek JS, Kraemer WJ, Bush JA, et al. Creatine supplementation enhances muscular performance during high-intensity resistance exercise. J Am Diet Assoc 1997;97:765-770.CrossRefGoogle Scholar
  50. 50.
    Tarnopolsky MA, MacLennan DP. Creatine monohydrate supplementation enhances high-intensity exercise performance in males and females. Int J Sport Nutr Exerc Metab 2000;10:452-463.Google Scholar
  51. 51.
    Wiroth TB, Bermon S, Andrei S, Dalloz E, Hebuterne X, Dolisi C. Effects of oral creatine supplementation on maximal pedalling performance in older adults. Eur J Appl Physiol 2001;84:533-539.CrossRefGoogle Scholar
  52. 52.
    Skare OC, Skadberg, Wisnes AR. Creatine supplementation improves sprint performance in male sprinters. Scand T Med Sci Sports 2001;11:96-102.CrossRefGoogle Scholar
  53. 53.
    Mujika I, Padilla S, Ibanez J, Izquierdo M, Gorostiaga E. Creatine supplementation and sprint performance in soccer players. Med Sci Sports Exerc 2000;32:518-525.CrossRefGoogle Scholar
  54. 54.
    Ostojic SM. Creatine supplementation in young soccer players. Int J Sport Nutr Exerc Metab 2004;14:95-103.Google Scholar
  55. 55.
    Theodorou AS, Cooke CB, King RF, et al. The effect of longer-term creatine supplementation on elite swimming performance after an acute creatine loading. J Sports Sci 1999;17:853-859.CrossRefGoogle Scholar
  56. 56.
    Mero AA, Keskinen KL, Malvela MT, Sallinen JM. Combined creatine and sodium bicarbonate supplementation enhances interval swimming. J Strength Cond Res 2004;18:306-310.Google Scholar
  57. 57.
    Preen D, Dawson B, Goodman C, Lawrence S, Beilby J, Ching S. Effect of creatine loading on long-term sprint exercise performance and metabolism. Med Sci Sports Exerc 2001;33:814-821.Google Scholar
  58. 58.
    Noonan D, Berg K, Latin RW, Wagner JC, Reimers K. Effects of varying dosages of oral creatine relative to fat free body mass on strength and body composition. J Strength Cond Res 1998;12:104-108.Google Scholar
  59. 59.
    Kirksey KB, Stone MH, Warren BJ, et al. The effects of 6 weeks of creatine monohydrate supplementation on performance measures and body composition in collegiate track and field athletes. J Strength Cond Res 1999;13:148-156.Google Scholar
  60. 60.
    Jones AM, Atter T, Georg KP. Oral creatine supplementation improves multiple sprint performance in elite ice-hockey players. J Sports Med Phys Fitness 1999;39:189-196.Google Scholar
  61. 61.
    Jowko E, Ostaszewski P, Jank M, et al. Creatine and beta-hydroxy-beta-methylbutyrate (HMB) additively increase lean body mass and muscle strength during a weight-training program. Nutrition 2001;17:558-566.CrossRefGoogle Scholar
  62. 62.
    Sipila I, Rapola J, Simell O, Vannas A. Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina. N Engl J Med 1981;304:867-870.CrossRefGoogle Scholar
  63. 63.
    Vannas-Sulonen K, Sipila I, Vannas A, Simell O, Rapola J. Gyrate atrophy of the choroid and retina. A five-year follow-up of creatine supplementation. Ophthalmology 1985;92:1719-1727.Google Scholar
  64. 64.
    Heinanen K, Nanto-Salonen K, Komu M, et al. Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinaemia. Eur J Clin Invest 1999;29:1060-1065.CrossRefGoogle Scholar
  65. 65.
    Nanto-Salonen K, Komu M, Lundbom N, et al. Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia. Neurology 1999;53:303-307.CrossRefGoogle Scholar
  66. 66.
    Ensenauer R, Thiel T, Schwab KO, et al. Guanidinoacetate methyltransferase deficiency: differences of creatine uptake in human brain and muscle. Mol Genet Metab 2004;82:208-213.CrossRefGoogle Scholar
  67. 67.
    Schulze A, Ebinger F, Rating D, Mayatepek E. Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab 2001; 74:413-419.CrossRefGoogle Scholar
  68. 68.
    Ganesan V, Johnson A, Connelly A, Eckhardt S, Surtees RA. Guanidinoacetate methyltransferase deficiency: new clinical features. Pediatr Neurol 1997;17:155-157.CrossRefGoogle Scholar
  69. 69.
    Zhu S, Li M, Figueroa BE, et al. Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice. J Neurosci 2004;24:5909-5912.CrossRefGoogle Scholar
  70. 70.
    Hausmann ON, Fouad K, Wallimann T, Schwab ME. Protective effects of oral creatine supplementation on spinal cord injury in rats. Spinal Cord 2002;40:449-456.CrossRefGoogle Scholar
  71. 71.
    Brustovetsky N, Brustovetsky T, Dubinsky JM. On the mechanisms of neuroprotection by creatine and phosphocreatine. J Neurochem 2001;76:425-434.CrossRefGoogle Scholar
  72. 72.
    Sullivan PG, Geiger JD, Mattson MP, Scheff SW. Dietary supplement creatine protects against traumatic brain injury. Ann Neurol 2000;48:723-729.CrossRefGoogle Scholar
  73. 73.
    Jacobs PL, Mahoney ET, Cohn KA, Sheradsky LF, Green BA. Oral creatine supplementation enhances upper extremity work capacity in persons with cervical-level spinal cord injury. Arch Phys Med Rehabil2002;83:19-23.CrossRefGoogle Scholar
  74. 74.
    Tarnopolsky MA. Potential use of creatine monohydrate in muscular dystrophy and neurometabolic disorders. Abstracts of 6th International Conference on Guanidino Compounds in Biology and Medicine, 2001.Google Scholar
  75. 75.
    Tarnopolsky MA, Parise G. Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease. Muscle Nerve 1999;22:1228-1233.CrossRefGoogle Scholar
  76. 76.
    Zange J, Kornblum C, Muller K, et al. Creatine supplementation results in elevated phosphocreatine/adenosine triphosphate (ATP) ratios in the calf muscle of athletes but not in patients with myopathies. Ann Neurol 2002;52:126; discussion 126-127.Google Scholar
  77. 77.
    Koumis T, Nathan JP, Rosenberg JM, Cicero LA. Strategies for the prevention and treatment of statin-induced myopathy: is there a role for ubiquinone supplementation? Am J Health Syst pharm 2004;61:515-519.Google Scholar
  78. 78.
    Borchert A, Wilichowski E, Hanefeld F. Supplementation with creatine monohydrate in children with mitochondrial encephalomyopathies. Muscle Nerve 1999;22:1299-1300.CrossRefGoogle Scholar
  79. 79.
    Tarnopolsky MA, Roy BD, MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 1997;20:1502-1509.CrossRefGoogle Scholar
  80. 80.
    Andreassen OA, Dedeoglu A, Ferrante RJ, et al. Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington’s disease. Neurobiol Dis 2001;8:479-491.CrossRefGoogle Scholar
  81. 81.
    Ferrante RJ, Andreassen OA, Jenkins BG, et al. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J Neurosci 2000;20:4389-4397.Google Scholar
  82. 82.
    Verbessem P, Lemiere J, Eijnde BO, et al. Creatine supplementation in Huntington’s disease: a placebo-controlled pilot trial. Neurology 2003;61:925-930.CrossRefGoogle Scholar
  83. 83.
    Andreassen OA, Jenkins BG, Dedeoglu A, et al. Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation. J Neurochem 2001;77:383-390.CrossRefGoogle Scholar
  84. 84.
    Tamopolsky MA. Potential benefits of creatine monohydrate supplementation in the elderly. Curr Opin Clin Nutr Metab Care 2000;3:497-502.CrossRefGoogle Scholar
  85. 85.
    Drory VE, Gross D. No effect of creatine on respiratory distress in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2002;3:43-46.CrossRefGoogle Scholar
  86. 86.
    Mazzini L, Balzarini C, Colombo R, et al. Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results. J Neurol Sci 2001;191:139-144.CrossRefGoogle Scholar
  87. 87.
    Willer B, Stucki G, Hoppeler H, Bruhlmann P, Krahenbuhl S. Effects of creatine supplementation on muscle weakness in patients with rheumatoid arthritis. Rheumatology (Oxford) 2000;39:293-298.CrossRefGoogle Scholar
  88. 88.
    Op ′t Eijnde B, Urso B, Richter EA, Greenhaff PL, Hespel P. Effect of oral creatine supplementation on human muscle GLUT4 protein content after immobilization. Diabetes 2001;50:18-23.CrossRefGoogle Scholar
  89. 89.
    Earnest CP, Almada A, Mitchell TL. High-performance capillary electrophoresispure creatine monohydrate reduced blood lipids in men and women. Clin Sci 1996;91: 113-118.Google Scholar
  90. 90.
    Jacobs RL, Stead LM, Ratnam S, Brosnan ME. Regulation of homocysteine metabolism-effects of insulin, glucagon and creatine. FASEB J 2001;15.Google Scholar
  91. 91.
    Steenge GR, Verhoef P, Greenhaff PL. The effect of creatine and resistance training on plasma homocysteine concentration in healthy volunteers. Arch Intern Med 2001;161: 1455-1456.CrossRefGoogle Scholar
  92. 92.
    McCarty MF. Supplemental creatine may decrease serum homocysteine and abolish the homocysteine “gender gap” by suppressing endogenous creatine synthesis. Med Hypotheses 2001;56:5-7.CrossRefGoogle Scholar
  93. 93.
    Taes YE, Delanghe JR, De Vriese AS, Rombaut R, Van Camp J, Larneire NH. Creatine supplementation decreases homocysteine in an animal model of uremia. Kidney Int 2003;64:1331-1337.CrossRefGoogle Scholar
  94. 94.
    Greenwood M, Kreider RB, Melton C, et al. Creatine supplementation during college football training does not increase the incidence of cramping or injury. Mol Cell Biochem 2003;244:83-88.CrossRefGoogle Scholar
  95. 95.
    Greenwood M, Kreider RB, Greenwood L, Byars A. Cramping and injury incidence in collegiate football players are reduced by creatine supplementation. J Athl Train 2003;38:216-219.Google Scholar
  96. 96.
    Greenwood M, Farris J, Kreider R, Greenwood L, Byars A. Creatine supplementation patterns and perceived effects in select division I collegiate athletes. Clin J Sport Med 2000;10:191-194.CrossRefGoogle Scholar
  97. 97.
    Greenwood M, Kreider R, Greenwood L, Byars A. Creatine supplementation does not increase the incidence of injury or cramping in college baseball players. J Exerc Physiol Online 2003;6:16-22.Google Scholar
  98. 98.
    Ortega Gallo PA, Dimeo F, Batista J, et al. Creatine supplementation in soccer players, effects in body composition and incidence of sport-related injuries. Med Sci Sports Exerc 2000;32:S134.Google Scholar
  99. 99.
    Volek JS, Ratamess NA, Rubin MR, et al. The effects of creatine supplementation on muscular performance and body composition responses to short-term resistance training overreaching. Eur J Appl Physiol 2004;91:628-637.CrossRefGoogle Scholar
  100. 100.
    Kreider R, Rasmussen C, Melton C, et al. Long-term creatine supplementation does not adversely affect clinical markers of health. Med Sci Sports Exerc 2000;32:S134.Google Scholar
  101. 101.
    Schroeder C, Potteiger J, Randall J, et al. The effects of creatine dietary supplementation on anterior compartment pressure in the lower leg during rest and following exercise. Clin J Sport Med 2001;11:87-95.CrossRefGoogle Scholar
  102. 102.
    Carper Mf, Potteiger JA, Randall JC, Jacobsen DF, Hulver MW, Thyfault JP. Lower leg anterior compartment pressure response prior to, during, and following chronic creatine supplementation. Med Sci Sports Exerc 2001;33.Google Scholar
  103. 103.
    Yoshizumi WM, Tsourounis e. Effects of creatine supplementation on renal function. J Herb Pharmcother 2004;4:1-7.CrossRefGoogle Scholar
  104. 104.
    Kreider RB, Melton C, Rasmussen q, et al. Long-term creatine supplementation does not significantly affect clinical markers of health in athletes. Mol Cell Biochem 2003;244:95-104.CrossRefGoogle Scholar
  105. 104.
    Schilling BK, Stone MH, Utter A, et al. Creatine supplementation and health variables: a retrospective study. Med Sci Sports Exerc 2001;33:183-188.CrossRefGoogle Scholar
  106. 106.
    Earnest CP, Almada A, Mitchell TL. Influence of chronic creatine supplementation on hepatorenal function. FASEB J 1996;10:A790.Google Scholar
  107. 107.
    Poortmans JR, Auquier H, Renaut V, Durusscl A, Saugy M, Brisson GR. Effect of short-term creatine supplementation on renal responses in men. Eur J Appl Physiol Occup Physiol 1997; 76:566-567.CrossRefGoogle Scholar
  108. 108.
    Poortmans JR, Francaux M. Long-term oral creatine supplementation does not impair renal function in healthy athletes. Med Sci Sports Exerc 1999;31:1108-1110.CrossRefGoogle Scholar
  109. 109.
    Robinson TM, Sewell DA, Casey A, Steenge G, Greenhaff PL. Dietary creatine supplementation does not affect some haernatological indices, or indices of muscle damage and hepatic and renal function. Br J Sports Med 2000;34:284-288.CrossRefGoogle Scholar
  110. 110.
    Kilduff LP, Georgiades E, James N, et al. The effects of creatine supplementation on cardiovascular, metabolic, and thermoregulatory responses during exercise in the heat in endurance-trained humans. Int J Sport Nutr Exerc Metab 2004; 14:443-460.Google Scholar
  111. 111.
    Volek JS, Mazzetti SA, Farquhar WB, Barnes BR, Gomez AL, Kraemer WJ. Physiological responses to short-term exercise in the heat after creatine loading. Med Sci Sports Exerc 2001;33:1101-1108.CrossRefGoogle Scholar
  112. 112.
    Kreider RB, Willoughby DS, Greenwood M, Parise G, Payne E, Tarnopolsky MA. Effects of serum creatine supplementation on muscle creatine content. J Exerc Physiol Online 2003;6:24-33.Google Scholar
  113. 113.
    Greenwood M, Kreider RB, Rasmussen C, Almada AL, Earnest CP. D-Pinitol augments whole body creatine retention in man. J Exerc Physiol Online 2001;4:41-47.Google Scholar
  114. 114.
    Gill ND, Hall RD, Blazevich AT. Creatine serum is not as effective as creatine powder for improving cycle sprint performance in competitive male team-sport athletes. J Strength Cond Res 2004;18:272-275.Google Scholar
  115. 115.
    Michaelis f, Vukovich MD. Effect of two different forms of creatine supplementation on muscular strength and power. Med Sci Sports Exerc 1998;30:S272.Google Scholar
  116. 116.
    Benzi G. Is there a rationale for the use of creatine either as nutritional supplementation or drug administration in humans participating in a sport? Pharmacol Res 2000;41 :255-264.CrossRefGoogle Scholar
  117. 117.
    Persky AM, Brazeau GA. Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev 2001;53:161-176.Google Scholar
  118. 118.
    Pearson DR, Hamby DG, Russel W, Harris T. Long-term effects of creatine monohydrate on strength and power. J Strength Cond Res 1999;13:187-192.Google Scholar
  119. 119.
    Cathcart EP. The influence of carbohydrates and fats on protein metabolism. J Physiol 1909;39:311-330.Google Scholar
  120. 120.
    Mendel LB, Rose WC. Experimental studies on creatine and creatinine: the role of the carbohydrates in creatine-creatinine metabolism. J BioI Chem 1911;10:213-253.Google Scholar
  121. 121.
    Benedict SR, Osterberg E. Studies in creatine and creatinine metabolism: III. On the origin of creatine. J Biol Chem 1914;18:195-214.Google Scholar
  122. 122.
    Chanutin A. A study of the effect of creatine on growth and its distribution in the tissues of normal rats. J Biol Chem 1927;75:549-557.Google Scholar
  123. 123.
    Chanutin A. A study of the effect of feeding creatine on growth and its distribution in the liver and muscle of normal mice. J Biol Chem 1928;78:167-180.Google Scholar
  124. 124.
    Schedel JM, Tanaka H, Kiyonaga A, Shindo M, Schutz Y. Acute creatine ingestion in human: consequences on serum creatine and creatinine concentrations. Life Sci 1999;65:2463-2470.CrossRefGoogle Scholar
  125. 125.
    Havenetidis K, Bourdas D. Creatine supplementation: effects on urinary excretion and anaerobic performance. J Sports Med Phys Fitness 2003;43:347-355.Google Scholar
  126. 126.
    Haughland RB, Chang DT. Insulin effects on creatine transport in skeletal muscle. Proc Soc Exp Biol Med 1975;148:1-4.Google Scholar
  127. 127.
    Salomons GS, van Dooren SJ, Verhoeven NM, et al. X-linked creatine transporter defect: an overview. J Inherit Metab Dis 2003;26:309-318.CrossRefGoogle Scholar
  128. 128.
    Queiroz MS, Berkich DA, Shao Y, Lanoue K, Ismail-Beigi F. Thyroid hormone regulation of cardiac creatine content: role of Na+/creatine transporter expression. FASEB J 2001;15.Google Scholar
  129. 129.
    Young JC, Young RE, Young CJ. The effect of creatine supplementation on glucose transport in rat skeletal muscle. FASEB J 2000;14.Google Scholar
  130. 130.
    Green AL, Simpson EJ, Littlewood JJ, Macdonald IA, Greenhaff P. Carbohydrate ingestion augments creatine retention during creatine feeding in humans. Acta Physiol Scand 1996;158:195-202.CrossRefGoogle Scholar
  131. 131.
    Green AL, Hultman E, Macdonald IA, Sewell DA, Greenhaff P. Carbohydrate feeding augments skeletal muscle creatine accumulation during creatine supplementation in humans. Am J Physiol 1996;271:E821-E826.Google Scholar
  132. 132.
    Borsheim E, Aarsland A, Wolfe RR. Effect of an amino acid, protein, and carbohydrate mixture on net muscle protein balance after resistance exercise. Int J Sport Nutr Exerc Metab 2004;14:255-271.Google Scholar
  133. 133.
    Borsheim E, Cree MG, Tipton KD, Elliott TA, Aarsland A, Wolfe RR. Effect of carbohydrate intake on net muscle protein synthesis during recovery from resistance exercise. J Appl Physiol 2004;96:674-678.CrossRefGoogle Scholar
  134. 134.
    Miller SL, Tipton KD, Chinkes DL, Wolf SE, Wolfe RR. Independent and combined effects of amino acids and glucose after resistance exercise. Med Sci Sports Exerc 2003;35:449-455.CrossRefGoogle Scholar
  135. 135.
    Bohe J, Low A, Wolfe RR, Rennie MJ. Human muscle protein synthesis is modulated by extracellular, not intramuscular amino acid availability: a dose-response study. J Physiol 2003;552:315-324.CrossRefGoogle Scholar
  136. 136.
    Wolfe RR. Regulation of muscle protein by amino acids. J Nutr 2002;132:3219S-3224S.Google Scholar
  137. 137.
    Doherty M, Smith PM, Davison RC, Hughes MG. Caffeine is ergogenic after supplementation of oral creatine monohydrate. Med Sci Sports Exerc 2002;34:1785-1792.CrossRefGoogle Scholar
  138. 138.
    Vandenberghe K, Van Hecke P, Van Leemputte M, Vanstapel F, Hespel P. Inhibition of muscle phosphocreatine resynthesis by caffeine after creatine loading. Med Sci Sports Exerc 1997;29:S249.Google Scholar
  139. 139.
    Vandenberghe K, Gillis N, Van Leemputte M, Van Hecke P, Vanstapel F, Hespel P. Caffeine counteracts the ergogenic action of muscle creatine loading. J Appl Physiol 1996;80:452-457.Google Scholar
  140. 140.
    Hespel P, Op't Eijnde B, Van Leemputte M. Opposite actions of caffeine and creatine on muscle relaxation time in humans. J Appl Physiol 2002;92:513-518.Google Scholar
  141. 141.
    Ray TR, Eck JC, Covington LA, Murphy RB, Williams R, Knudtson J. Use of oral creatine as an ergogenic aid for increased sports performance: perceptions of adolescent athletes. South Med J 2001;94:608-612.Google Scholar
  142. 142.
    Smith J, Dahm DL. Creatine use among a select population of high school athletes. Mayo Clin Proc 2000;75:1257-1263.CrossRefGoogle Scholar
  143. 143.
    Sheppard HL, Raichada SM, Kouri KM, Stenson-Bar-Maor L, Branch JD. Use of creatine and other supplements by members of civilian and military health clubs: a cross-sectional survey. Int J Sport Nutr Exerc Metab 2000;10:245-259.Google Scholar
  144. 144.
    Tyler TF, Nicholas SJ, Hershman EB, Glace BW, Mullaney MJ, McHugh MP. The effect of creatine supplementation on strength recovery after anterior cruciate ligament (ACL) reconstruction: a randomized, placebo-controlled, double-blind trial Am J Sports Med 2004;32:383-388.CrossRefGoogle Scholar
  145. 145.
    Hespel P, Op′t Eijnde B, Van Leemputte M, et al Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans. J Physiol 2001;536:625-633.CrossRefGoogle Scholar

Copyright information

© Humana Press. a part of Spring Science+Business Media, LLC 2008

Authors and Affiliations

  • Richard B. Kreider

There are no affiliations available

Personalised recommendations